The CAB Epigenetics Group focuses on helping researchers answer biological questions related to regulation through epigenetic mechanisms using the best available tools. We are also interested in establishing new analytic pipelines to enhance researching practices of St. Jude investigators.
We mainly expereinced on areas:
We categorized Epigenetics Analyses briefly into three major topics:
The CAB Epigenetics is primarily a bioinformatic group that uses a wide range of genomic, bioinformatic, and statistical methods including:
If you are interested in joining please go to the recruitment page.
We are grateful for funding from the National Cancer Institute at National Institute of Health
New papers! Yang et al. 2024; NucleicAcidsRes.;Mondal et al. 2023; CancerRes;Ho et al. 2023; JClinInvest;Barajas et al. 2023; Blood;Kamens et al. 2023; NatCommun;Matsui et al. 2023; NatCommun;Searcy et al. 2023; NatCommun;Tian et al. 2023; Oncogene;Wright et al. 2023; Proc.Natl.Acad.Sci.;Surman et al. 2023; Viruses;Ranjit et al. 2024; DrugResist.Updates;
New papers! Zhao et al. 2022; NatCommun;Singh et al. 2022; Sci.Transl.Med.;Jiao et al. 2023; CellReports;Wang et al. 2023; Sci.Adv.; Kudo to Nadhir, co-first author Hyle et al. 2023; GenomeBiol.; Press Release
New papers! Dickerson et al. 2022; BloodCancerDiscovery;Zhao et al. 2022; JNCI;Drosos et al. 2022; MolecularCell;Graca et al. 2022; NatCommun; Kudo to Wojciech, co-first author Qi et al. 2022; JPathol
New paper! Wang et al. 2021 published in Life Sci. Alliance: PROSER1 mediates TET2 O-GlcNAcylation to regulate DNA demethylation on UTX-dependent enhancers and CpG islands. Kudo to Wojciech, first co-first author with St. Jude PIs
New paper! Xu et al. 2021 published in Genome Bio.: Acute depletion of CTCF rewires genome-wide chromatin accessibility. Press Release